Axiogenesis Cor.At mESC cardiomyocytes

Monday, 21 June, 2010 | Supplied by: Lonza Australia Pty Ltd


Msf249

Embryonic stem cell-derived cardiomyocytes have many of the phenotypic properties of primary cardiomyocytes and show great potential to model human diseases. The Cor.At cells are cardiomyocytes derived from transgenic mouse embryonic stem cells and are available cryopreserved in ampoules.

The cells are highly pure with ampoules containing 99% cardiomyocytes. Their minimal lot-to-lot variation is claimed to give consistent performance and the standardised production process ensures stable supply.

The cardiomyocytes are a good predictive model with relevant background including all important ion channels well characterised.

They are suitable for applications including: electrophysiology (patch clamp, microelectrode arrays, Ca2+ flux analysis), non-arrhythmic cardiotoxicity (cell viability, label-free analysis, troponin release), drug profiling and target discovery (hypertrophy, gene expression, transfection, tissue engineering).

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

Lonza BulletKit Growth Media

BulletKit Media provides researchers with added flexibility and reduced variability across their...

EXAIR Ion Air Cannon

EXAIR's Ion Air Cannon eliminates static electricity and cleans at distances up to 4.6 m,...

Innova Biosciences LATEX Bead Conjugation Kits

Innova Biosciences has introduced a range of LATEX Bead Conjugation Kits. The simple-to-use,...


  • All content Copyright © 2017 Westwick-Farrow Pty Ltd